Civitas Therapeutics' Grant

Civitas Therapeutics raised a round of funding on June 19, 2013. Investors include The Michael J. Fox Foundation.

Civitas is a privately-held biopharmaceutical company focused on developing a pipeline of inhaled therapeutics with the clinically proven ARCUS dry powder pulmonary delivery platform. In addition to t…

Articles about Civitas Therapeutics' Grant: